FR2875501B1 - Nouveaux derives peptidiques, compositions et utilisations dans un traitement therapeutique de l'infection par un herpesvirus - Google Patents

Nouveaux derives peptidiques, compositions et utilisations dans un traitement therapeutique de l'infection par un herpesvirus

Info

Publication number
FR2875501B1
FR2875501B1 FR0409969A FR0409969A FR2875501B1 FR 2875501 B1 FR2875501 B1 FR 2875501B1 FR 0409969 A FR0409969 A FR 0409969A FR 0409969 A FR0409969 A FR 0409969A FR 2875501 B1 FR2875501 B1 FR 2875501B1
Authority
FR
France
Prior art keywords
compositions
therapeutic treatment
peptide derivatives
novel peptide
herpesvirus infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0409969A
Other languages
English (en)
Other versions
FR2875501A1 (fr
Inventor
Nicolas Dupin
Philippe Alain Grange
Vincent Calvez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Paris 5 Rene Descartes
Original Assignee
Universite Paris 5 Rene Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Paris 5 Rene Descartes filed Critical Universite Paris 5 Rene Descartes
Priority to FR0409969A priority Critical patent/FR2875501B1/fr
Priority to PCT/FR2005/002331 priority patent/WO2006032781A2/fr
Publication of FR2875501A1 publication Critical patent/FR2875501A1/fr
Application granted granted Critical
Publication of FR2875501B1 publication Critical patent/FR2875501B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR0409969A 2004-09-21 2004-09-21 Nouveaux derives peptidiques, compositions et utilisations dans un traitement therapeutique de l'infection par un herpesvirus Expired - Fee Related FR2875501B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0409969A FR2875501B1 (fr) 2004-09-21 2004-09-21 Nouveaux derives peptidiques, compositions et utilisations dans un traitement therapeutique de l'infection par un herpesvirus
PCT/FR2005/002331 WO2006032781A2 (fr) 2004-09-21 2005-09-20 Derives peptidiques , compositions et utilisations dans un traitement therapeutique de l’infection par un herpevirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0409969A FR2875501B1 (fr) 2004-09-21 2004-09-21 Nouveaux derives peptidiques, compositions et utilisations dans un traitement therapeutique de l'infection par un herpesvirus

Publications (2)

Publication Number Publication Date
FR2875501A1 FR2875501A1 (fr) 2006-03-24
FR2875501B1 true FR2875501B1 (fr) 2008-02-29

Family

ID=34950862

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0409969A Expired - Fee Related FR2875501B1 (fr) 2004-09-21 2004-09-21 Nouveaux derives peptidiques, compositions et utilisations dans un traitement therapeutique de l'infection par un herpesvirus

Country Status (2)

Country Link
FR (1) FR2875501B1 (fr)
WO (1) WO2006032781A2 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869446A (en) * 1996-07-09 1999-02-09 Gambit International Limited Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections
US6172040B1 (en) * 1999-05-28 2001-01-09 A. Satyanarayan Naidu Immobilized lactoferrin antimicrobial agents and the use thereof
JPWO2002077239A1 (ja) * 2001-03-27 2004-07-15 住友製薬株式会社 Ｈｃｖ結合性ポリペプチド
JP3726095B2 (ja) * 2002-11-29 2005-12-14 森永乳業株式会社 プロテアーゼ阻害剤

Also Published As

Publication number Publication date
WO2006032781A3 (fr) 2006-08-31
FR2875501A1 (fr) 2006-03-24
WO2006032781A2 (fr) 2006-03-30

Similar Documents

Publication Publication Date Title
MA27374A1 (fr) Ester de 2'-c-methyl-3'-o-l-valine et de ribofuranosyl cytidine pour le traitement des infections des flaviviridae
GB0612417D0 (en) Compositions and methods for topical treatment of skin infection
NO20075046L (no) Gastroresistente farmasoytiske formuleringer inneholdende rifaximin
EP1689348A4 (fr) Composition d'oligosaccharides et leur utilisation dans le traitement d'infection
BRPI0513370A (pt) uso de uma combinação de ciclosporina e interferonas peguilados para tratamento de hepatite c (hcv)
EA200602137A1 (ru) Гидрогелевые препараты интерферона
FR2868780B1 (fr) Derives de la 1-amino-phthalazine, leur preparation et leur application en therapeutique
FR2873691B1 (fr) Derives d'amino-piperidine, leur preparation et leur application en therapeutique
IL171991A0 (en) Use of an interferon polypeptide in the preparation of a pharmaceutical composition for treating virus infection and a method of treating a virus-infected non human subject
MA28343A1 (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
EA200702523A1 (ru) Применение эритропоэтина в низкой дозировке для стимуляции эндотелиальных клеток-предшественников, а также для регенерации органов и замедления прогрессирования повреждений конечных органов
FR2872813B1 (fr) Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique
CY2007033I2 (el) Μεθοδος και φαρμακευτικο σκευασμα για την αντιμετωπιση της αντιστασης στα αντιυπερτασικα φαρμακα και για σχετικες παθησεις
MA29017B1 (fr) Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
FR2866888B1 (fr) Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en therapeutique
EA201170484A1 (ru) Терапевтический режим лечения гепатита, включающий пэг-интерферон, рибавирин и vx-950
EA200200922A1 (ru) Композиция, включающая камптотецин и производное пиримидина, для лечения рака
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
EA200500871A1 (ru) Пептиды, ингибирующие ангиогенез, миграцию клеток, инвазию клеток и пролиферацию клеток, композиции и их применение
ATE413187T1 (de) Pharmazeutische zusammensetzungen mit interferon- tau
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
EE200400074A (et) Koostised ning nende kasutamine proliferatiivsetehaiguste raviks
FR2845991B1 (fr) Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine
FR2875501B1 (fr) Nouveaux derives peptidiques, compositions et utilisations dans un traitement therapeutique de l'infection par un herpesvirus

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150529